Effect on Hemoglobin A1c (HbA1c) and Body Weight After Discontinuation of Tirzepatide, a Novel Glucose-Dependent Insulinotropic Peptide (GIP) and Glucagon-Like Peptide-1 (GLP-1) Receptor Agonist: A Single-Center Case Series Study

Introduction The purpose of this study was to examine changes in blood glucose levels and body weight after discontinuation of tirzepatide, a novel long-acting dual glucose-dependent insulinotropic peptide (GIP) and glucagon-like peptide-1 receptor agonist (GLP-1 RA). Methods Nine subjects (five mal...

Descripción completa

Detalles Bibliográficos
Autores principales: Kubota, Mitsunobu, Yamamoto, Kazuki, Yoshiyama, Sayo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Endocrinology/Diabetes/Metabolism
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10550307/
https://www.ncbi.nlm.nih.gov/pubmed/37800161
http://dx.doi.org/10.7759/cureus.46490

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10550307/
https://www.ncbi.nlm.nih.gov/pubmed/37800161
http://dx.doi.org/10.7759/cureus.46490

Ejemplares similares